|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bareschino MA, Schettino C, Rossi A,
Maione P, Sacco PC, Zeppa R and Gridelli C: Treatment of advanced
non small cell lung cancer. J Thorac Dis. 3:122–133.
2011.PubMed/NCBI
|
|
3
|
Zeng H, Zheng R, Guo Y, Zhang S, Zou X,
Wang N, Zhang L, Tang J, Chen J, Wei K, et al: Cancer survival in
China, 2003-2005: A population-based study. Int J Cancer.
136:1921–1930. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Waters JS and O'Brien ME: The case for the
introduction of new chemotherapy agents in the treatment of
advanced non small cell lung cancer in the wake of the findings of
the national institute of clinical excellence (NICE). Br J Cancer.
87:481–490. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fernet M and Hall J: Genetic biomarkers of
therapeutic radiation sensitivity. DNA Repair (Amst). 3:1237–1243.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ulrich CM, Robien K and McLeod HL: Cancer
pharmacogenetics, Polymorphisms, pathways and beyond. Nat Rev
Cancer. 3:912–920. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Townsend PA, Cutress RI, Sharp A, Brimmell
M and Packham G: BAG-1: A multifunctional regulator of cell growth
and survival. Biochim Biophys Acta. 1603:83–98. 2003.PubMed/NCBI
|
|
8
|
Takayama S, Sato T, Krajewski S, Kochel K,
Irie S, Millan JA and Reed JC: Cloning and functional analysis of
BAG-1G1: A novel Bcl-2-binding protein with anti-cell death
activity. Cell. 80:279–284. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Townsend PA, Stephanou A, Packham G and
Latchman DS: BAG-1G1: A multi-functional pro-survival molecule. Int
J Biochem Cell Biol. 37:251–259. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang L, McBurney D, Tang SC, Carlson SG
and Horton WE Jr: A novel role for Bcl-2 associated-athanogene-1
(Bag-1) in regulation of the endoplasmic reticulum stress response
in mammalian chondrocytes. J Cell Biochem. 102:786–800. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rorke S, Murphy S, Khalifa M, Chernenko G
and Tang SC: Prognostic significance of BAG-1 expression in
nonsmall cell lung cancer. Int J Cancer. 95:317–322. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu H, Bai Y, Liu B, Wang Z, Wang M, Zhou
Q and Chen J: The expression of BAG-1 and its clinical significance
in human lung cancer. Zhongguo Fei Ai Za Zhi. 11:489–494. 2008.(In
Chinese). PubMed/NCBI
|
|
13
|
Gotz R, Kramer BW, Camarero G and Rapp UR:
BAG-1 haplo-insufficiency impairs lung tumorigenesis. BMC Cancer.
4:852004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Greene FL, Page DL, Fritz AG, et al: Lung.
AJCC Cancer Staging Manual (6th). (New York, NY). Springer.
170–171. 2001.
|
|
15
|
Karnofsky DA and Burchenal JH: The
clinical evaluation of chemotherapeutic agents in cancer.
Evaluation of Chemotherapeutic Agents. MacLeod CM: (New York, NY).
Columbia University Press. 191–205. 1949.
|
|
16
|
Therasse P, Arbuck SG, Eisenhauer EA,
Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van
Oosterom AT, Christian MC and Gwyther SG: New guidelines to
evaluate the response to treatment in solid tumors. Histopathology.
J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lowry OH, Rosebrough NJ, Farr AL and
Randall RJ: Protein measurement with the Folin phenol reagent. J
Biol Chem. 193:265–275. 1951.PubMed/NCBI
|
|
18
|
Xu C, Bailly-Maitre B and Reed JC:
Endoplasmic reticulum stress, Cell life and death decisions. J Clin
Invest. 115:2656–2664. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakagawa T, Zhu H, Morishima N, Li E, Xu
J, Yankner BA and Yuan J: Caspase-12 mediates
endoplasmic-reticulum-specific apoptosis and cytotoxicity by
amyloid-beta. Nature. 403:98–103. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH: Eastern
Cooperative Oncology Group. Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gurubhagavatula S, Liu G, Park S, Zhou W,
Su L, Wain JC, Lynch TJ, Neuberg DS and Christiani DC: XPD and
XRCC1 genetic polymorphisms are prognostic factors in advanced
non-small-cell lung cancer patients treated with platinum
chemotherapy. J Clin Oncol. 22:2594–2601. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Booton R, Ward T, Heighway J, Taylor P,
Power F, Ashcroft L, Morris J and Thatcher N: Xeroderma pigmentosum
group D haplotype predicts for response, survival and toxicity
after platinum-based chemotherapy in advanced nonsmall cell lung
cancer. Cancer. 106:2421–2427. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim SH, Juhnn YS and Song YS: Akt
involvement in paclitaxel chemoresistance of human ovarian cancer
cells. Ann NY Acad Sci. 1095:82–89. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Matakidou A, El Galta R, Webb EL, Rudd MF,
Bridle H, Gelcaps Consortium, Eisen T and Houlston RS: Genetic
variation in the DNA repair genes is predictive of outcome in lung
cancer. Hum Mol Genet. 16:2333–2340. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu X, Lu C, Ye Y, Chang J, Yang H, Lin J,
Gu J, Hong WK, Stewart D and Spitz MR: Germline genetic variations
in drug action pathways predict clinical outcomes in advanced lung
cancer treated with platinum-based chemotherapy. Pharmacogenet
Genomics. 18:955–965. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu H, Bai Y, Liu B, Wang Z, Wang M, Zhou
Q and Chen J: The expression of BAG-1 and its clinical significance
in human lung cancer. Zhongguo Fei Ai Za Zhi. 11:489–494.
2008.PubMed/NCBI
|
|
27
|
Morishima N, Nakanishi K, Takenouchi H,
Shibata T and Yasuhiko Y: An endoplasmic reticulum stress-specific
caspase cascade in apoptosis. Histopathology. J Biol Chem.
277:34287–34294. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tan Y, Dourdin N, Wu C, De Veyra T, Elce
JS and Greer PA: Ubiquitous calpains promote caspase-12 and JNK
activation during endoplasmic reticulum stress-induced apoptosis. J
Biol Chem. 281:16016–16024. 2006. View Article : Google Scholar : PubMed/NCBI
|
